Fig. 5From: Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patientsProtein expression and intracellular localization of LanCL2 was correlated with the grade of gliomas. A Immunohistochemistry analysis of LanCL2 in representative sections of grade I to IV gliomas. Sections of white matter and cortex were used for comparison. Bar = 20 μm. B IHC staining scores of LanCL2 in tumor sections. C Immunohistochemistry analysis of EGFR in representative sections of grade I to IV gliomas. Bar = 20 μm. D IHC staining scores of EGFR in tumor sections. P values were determined by Kruskal–Wallis One-Way ANOVA and Dunn’s multiple comparisons. *p < 0.05; **p < 0.01Back to article page